Impurities in pharmaceuticals are a major concern for drug manufacturers. This article will discuss the importance of ...

The drug has shown 20 per cent benefit over enalapril, so saying Entresto should cost 20 per cent more is ludicrous and "that's not going to foster innovation," he finished. About the author ...

Sacubitril/valsartan significantly reduced cardiomyopathy ... A well-known heart failure (HF) drug showed promise for blocking cardiotoxic effects in patients taking anthracycline chemotherapy ...

MSN Pharma was given FDA approval for its Entresto (sacubitril and valsartan) generic on 24th July, prompting a lawsuit from Novartis claiming patent infringement and seeking a preliminary ...

INR:1749. ipl today betting rate Changchun High-Tech plans to spin off its subsidiary Beike Biotech and list it on the Science and Technology Innovation Bo ...

Our top content from the 100th annual American Heart Association (AHA) Scientific Sessions included exclusive expert insights ...

Cyclosporine-drug interactions in adult transplant patients and the impact of age were studied. The medical records of transplant patients receiving cyclosporine therapy were identified.

Doses were titrated over 6 months (daily maximums, 160 mg and 10 mg, respectively), and agents from other drug classes were ... treatment previously. Valsartan's manufacturer sponsored the trial.

The U.S. Food and Drug Administration classified capsules ... More than 12 million bottles of blood pressure-lowering drugs such as valsartan and losartan have been removed from the market ...

Indian pharma adopts Patient-Centric Pharmaceutical Product Design to improve medication adherence: Nandita Vijayasimha, Bengaluru Thursday, December 26, 2024, 08:00 Hrs [IST] Ind ...